Thomas J Paulson's Net Worth
-$52.3 Thousand
Who is Thomas J Paulson?
Thomas J Paulson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NovaBay Pharmaceuticals, Inc., and AVIGEN INC \DE.
SEC CIK
Thomas J Paulson's CIK is 0001256960
Past Insider Trading and Trends
2008 was Thomas J Paulson's most active year for acquiring shares with 7 total transactions. Thomas J Paulson's most active month to acquire stocks was the month of August. 2013 was Thomas J Paulson's most active year for disposing of shares, totalling 2 transactions. Thomas J Paulson's most active month to dispose stocks was the month of September. 2011 saw Thomas J Paulson paying a total of $46,609.95 for 99,500 shares, this is the most they've acquired in one year. In 2013 Thomas J Paulson cashed out on 113,645 shares for a total of $6,378.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NovaBay Pharmaceuticals, Inc. (NBY) Snapshot price: $0.1315
CFOThomas J Paulson owns 68,210 units of Common Stock which is worth $8,969.62 and 142,196 units of Restricted Stock Unit which is worth $18,698.77. From 2008 to 2017 Thomas J Paulson acquired a total of 161,486 shares in NovaBay Pharmaceuticals, Inc. at a cost of $91,112.95, Thomas also disposed a total of 7,290 shares of NovaBay Pharmaceuticals, Inc. equalling to $11,153.70.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +54.23% | 50K |
—
|
—
| 142.2K |
Oct 5
| |||
Form 4
| +35.16% | 23.99K |
—
|
—
| 92.2K |
Mar 23
| |||
Form 4
| +17.18% | 10K |
$0.68 | $6,800.00 | 68.21K |
Dec 12
| |||
Form 4
| +20.74% | 10K |
$0.67 | $6,700.00 | 58.21K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
| -5.40% | -3.65K |
$1.75 | -$6,378.75 | 63.85K |
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +18.57% | 10K |
$1.24 | $12,400.00 | 63.85K |
Dec 6
| |||
Form 4
| -6.34% | -3.65K |
$1.31 | -$4,774.95 | 53.85K |
Oct 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
| +133.33% | 10K |
$0.94 | $9,364.00 | 17.5K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
∞
| 40K |
$1.09 | $43,600.00 | 40K |
Oct 27
| |||
Form 4
| +87.50% | 3.5K |
$0.86 | $3,009.95 | 7.5K |
Aug 26
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| +100.00% | 2K |
$1.92 | $3,839.00 | 4K |
Sep 11 - Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 4
|
∞
| 2K |
$2.70 | $5,400.00 | 2K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVIGEN INC \DE No price found
Chief Finance Officer & Secty
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
| No matching records found | |||||||||